Literature DB >> 15915328

[Histopathology of squamous cell carcinoma and adenocarcinoma of the uterine cervix].

D Schmidt1, L-C Horn, F Kommoss.   

Abstract

The introduction of a screening programme for carcinoma of the cervix uteri has lead to a reduction in the number of invasive carcinomas and to a relative increase in the frequency of preinvasive cervical lesions. The most frequent type of invasive cancer of the cervix is squamous cell carcinoma. Adenocarcinomas are much more infrequent. Special subtypes of squamous cell carcinomas are the papillary (squamotransitional) subtype, the verrrucous subtype and the lymphoepithelioma-like subtype. Among the various forms of adenocarcinoma, the mucinous subtype is the most frequent, either as endocervical or interstinal subtype. Much more rare are the serous and clear cell carcinomas. Great concern in daily diagnosis causes the adenoma malignum (minimal deviation adenocarcinoma), since this type of adenocarcinoma demonstrates only minor cytological atypia and greatly resembles the different types of endocervical glandular hyperplasia.A report on a cervical carcinoma should always include the typing and grading of the tumor. Immunohistochemical stains are often useful to distinguish the various types of primary cervical cancer and to distinguish these from metastatic lesions.

Entities:  

Mesh:

Year:  2005        PMID: 15915328     DOI: 10.1007/s00292-005-0765-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  15 in total

1.  Utility of the monoclonal antibody HIK1083 in the diagnosis of adenoma malignum of the uterine cervix.

Authors:  K Utsugi; Y Hirai; N Takeshima; F Akiyama; S Sakurai; K Hasumi
Journal:  Gynecol Oncol       Date:  1999-12       Impact factor: 5.482

2.  Carcinoma of the cervix uteri.

Authors:  J L Benedet; F Odicino; P Maisonneuve; U Beller; W T Creasman; A P Heintz; H Y Ngan; M Sideri; S Pecorelli
Journal:  J Epidemiol Biostat       Date:  2001

3.  Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.

Authors:  J Ordi; F F Nogales; A Palacin; M Márquez; J Pahisa; J A Vanrell; A Cardesa
Journal:  Am J Surg Pathol       Date:  2001-12       Impact factor: 6.394

4.  Mitotic activity and apoptosis in endocervical glandular lesions.

Authors:  Suzuko Moritani; Olga B Ioffe; Satoru Sagae; Laila Dahmoush; Steven G Silverberg; Takanori Hattori
Journal:  Int J Gynecol Pathol       Date:  2002-04       Impact factor: 2.762

5.  Mesonephric adenocarcinoma of the uterine cervix with focal endocrine cell differentiation.

Authors:  C J Stewart; C R Taggart; F Brett; A F Mutch
Journal:  Int J Gynecol Pathol       Date:  1993-07       Impact factor: 2.762

Review 6.  Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis.

Authors:  R H Young; P B Clement
Journal:  Histopathology       Date:  2002-09       Impact factor: 5.087

7.  Younger age as a bad prognostic factor in patients with carcinoma of the cervix.

Authors:  J F Delaloye; S Pampallona; P A Coucke; P De Grandi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1996-02       Impact factor: 2.435

Review 8.  Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component.

Authors:  P B Clement; R H Young; P Keh; A G Ostör; R E Scully
Journal:  Am J Surg Pathol       Date:  1995-10       Impact factor: 6.394

Review 9.  Symposium part II: special types of adenocarcinoma of the uterine cervix.

Authors:  William R Hart
Journal:  Int J Gynecol Pathol       Date:  2002-10       Impact factor: 2.762

10.  Lymphoepithelioma-like carcinoma of the uterine cervix. A distinctive, undifferentiated carcinoma with inflammatory stroma.

Authors:  S E Mills; M B Austin; M E Randall
Journal:  Am J Surg Pathol       Date:  1985-12       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.